About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durvalumab Effective in Advanced Disease?
By
The University of Kansas Cancer Center 2020 ASCO Highlights
FEATURING
Anwaar Saeed
By
The University of Kansas Cancer Center 2020 ASCO Highlights
FEATURING
Anwaar Saeed
159 views
September 9, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
2020 ASCO Highlights
10:04
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on ES-SCLC: Does the Addition of Anti-CTLA-4 Tremel…
Feat.
J. Zhang
13:10
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO NSCLC Highlights: Can We Consider Nivo + Ipi a Novel Chemo…
Feat.
J. Zhang
08:14
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Highlights on NSCLC Targeted Therapy: T-DXd for HER2-Mutat…
Feat.
J. Zhang
08:28
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on mCRC: Does T-DXd Have Potential in HER2+ Disease…
Feat.
A. Saeed
12:44
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuv…
Feat.
A. Saeed
11:42
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on MSI-H mCRC: Is Pembrolizumab More Beneficial Tha…
Feat.
A. Saeed
09:40
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durva…
Feat.
A. Saeed
09:55
The University of Kansas Cancer Center 2020 ASCO Highlights
ASCO 2020 Updates on Epithelial Ovarian Cancer: How Effective Is Sec…
Feat.
A. Jewell,
C. Salyer
07:24
The University of Kansas Cancer Center 2020 ASCO Highlights
ASCO 2020 Updates on Cervical Cancer and GTD: Sequential Chemo vs. R…
Feat.
A. Jewell,
C. Salyer
14:55
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on Neoadjuvant Therapy in TNBC: Does Sequential AC/…
Feat.
P. Sharma
06:08
The University of Kansas Cancer Center 2020 ASCO Highlights
2020 ASCO Update on Neoadjuvant Therapy in TNBC: How Effective Is th…
Feat.
P. Sharma
18:35
The University of Kansas Cancer Center 2020 ASCO Highlights
ASCO 2020 Symptoms and Survivorship Highlights: Does Early Palliativ…
Feat.
E. Wulff-Burchfield
